Baxter Buys Gambro For $4 Billion To Round Out Dialysis Device Lineup

Deal builds on Baxter’s home peritoneal dialysis-focused business by adding a suite of products for hemodialysis in the clinic, including Gambro’s Artis and AK 96 systems.

Baxter International Inc. will significantly broaden its dialysis product offerings through its acquisition of privately held Gambro AB for $4 billion, the diversified medical products firm announced Dec. 4.

Based in Lund, Sweden, Gambro is a global provider of devices for hemodialysis and continuous renal replacement therapy for both chronic and acute care in institutional settings. The firm generated...

More from Deals

More from Business